VERIGENE SYSTEM, VERIGENE WARFARIN METABOLISM NUCLEIC ACID TEST

Cytochrome P450 2c9 (cyp450 2c9) Drug Metabolizing Enzyme Genotyping System

NANOSPHERE, INC

The following data is part of a premarket notification filed by Nanosphere, Inc with the FDA for Verigene System, Verigene Warfarin Metabolism Nucleic Acid Test.

Pre-market Notification Details

Device IDK070804
510k NumberK070804
Device Name:VERIGENE SYSTEM, VERIGENE WARFARIN METABOLISM NUCLEIC ACID TEST
ClassificationCytochrome P450 2c9 (cyp450 2c9) Drug Metabolizing Enzyme Genotyping System
Applicant NANOSPHERE, INC 4088 COMMERCIAL AVENUE Northbrook,  IL  60062
ContactSue Kent
CorrespondentSue Kent
NANOSPHERE, INC 4088 COMMERCIAL AVENUE Northbrook,  IL  60062
Product CodeODW  
Subsequent Product CodeNSU
Subsequent Product CodeODV
CFR Regulation Number862.3360 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2007-03-23
Decision Date2007-09-17
Summary:summary

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.